Brocacef Nl:eu HUB Pharmaceutical Import Profile — Netherlands (DGFT 2022–2026)

Name: Brocacef Nl:eu HUB Pharmaceutical Import Records from India — 2 Products, $1.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Brocacef Nl:eu HUB — Pharmaceutical Importer Profile (2026) | 2 Products, $1.7M Trade | TransData Nexus

Brocacef Nl:eu HUB

Pharmaceutical Importer · Netherlands · Diuretics Focus · $1.7M Total Trade · DGFT Verified

Brocacef Nl:eu HUB is a pharmaceutical importer based in Netherlands with a total trade value of $1.7M across 2 products in 2 therapeutic categories. Based on 65 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Brocacef Nl:eu HUB sources from 1 verified Indian supplier, with Intas Pharmaceuticals Limited accounting for 100.0% of imports.

Brocacef Nl:eu HUB — Import Portfolio & Supplier Network

Brocacef Nl:eu HUB import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Brocacef Nl:eu HUB?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Intas Pharmaceuticals Limited	$5.5M	431	100.0%

Brocacef Nl:eu HUB sources from 1 verified Indian supplier across 208 distinct formulations. The sourcing is highly concentrated — Intas Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Pharma drugs & medi spironolactone 50mg10x10t(accord-germany as per	$490.1K	19
Pharma drugs & medi spironolactone 25mg10x10t(accord-germany as per	$429.4K	16
Pharma drugs & medi olmes/amlo 40MG+10mg7x14t(accord-germany as per	$199.0K	10
Pharma drugs & medi gabapentin 400MG 100c hdpe(aco-denmark as per	$197.2K	7
Pharma drugs & medi argatroban,1MG/ML,50ML(accord-germany as per	$192.2K	8
Pharma drugs & medi olmes/amlo 20MG+5MG 7x14t(accord-germany as per	$168.2K	14
Pharma drugs & medi olmes/amlo 40MG+5MG 7x14t(accord-germany as per	$137.0K	6
Pharm drug&med:spironolactone 25mg10x10t(accord-germany)Each film coated tabletcont:spironolactone ph. eur...25MG	$109.4K	3
Pharma drugs & medi spironolactone 25mg10x10t(accord- germany as per	$100.0K	4
Pharm drug&med:spironolactone 25mg10x10t(accord-german)Each film coated tablet contains: spironolactone ph. eur...25MG	$89.1K	2
Pharma drugs & medi bupropion 300MG 9x10t(accord-germany as per	$79.6K	4
Pharm drug&med:eplerenone 25MG 10x10t (aco-pp-dk/se/no)Each film coated tablet contains: eplerenone...25MG	$70.8K	2
Pharm drug&med:eplerenone 25MG 10x10t (aco-pp-dk/se/no)Each film coated tablet contains: eplerenone...25MG	$69.9K	2
Pha.dru & medi, tacrolimus ointmen,0.1%,30g/t(aco-fidk Each GM contains: tacrolimus monohydrate eq. to	$64.8K	5
Pharma drugs & medi escitalopram 20MG 7x14t(accord-sweden as per	$60.1K	6

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Spironolactone	Diuretics	$1.6M	57	0.8%	11
2	Topotecan	Advanced Oncology	$70.0K	8	1.9%	11

Brocacef Nl:eu HUB imports 2 pharmaceutical products across 2 categories into Netherlands totaling $1.7M.

Brocacef Nl:eu HUB — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Brocacef Nl:eu HUB is a pharmaceutical importer and buyer based in the Netherlands, operating under the Brocacef Group, which has a rich history dating back to 1798 when founded by Willem Brocades in Meppel. The company has evolved into a significant player in the Dutch pharmaceutical sector, providing comprehensive healthcare logistics and services to a diverse clientele, including pharmacies, hospitals, general practitioners, nursing homes, suppliers, healthcare insurers, and private individuals. (brocacef.nl)

As part of the Brocacef Group, Brocacef Nl:eu HUB contributes to the organization's extensive network, which includes approximately 5,300 employees and a nationwide presence with around 350 BENU pharmacies. The group's annual revenue is approximately €2.8 billion, reflecting its substantial impact on the healthcare industry. (bitscale.ai)

2Distribution Network

Brocacef Nl:eu HUB operates a robust distribution network within the Netherlands, with a significant warehouse located in Ede. This facility enables efficient storage and distribution of pharmaceutical products across the country. The company's logistics capabilities are designed to ensure timely and reliable delivery to various healthcare providers, including pharmacies, hospitals, and nursing homes. While the primary focus is on the Dutch market, Brocacef's affiliation with the German PHOENIX Group suggests potential for broader European distribution, leveraging the group's extensive logistics infrastructure. (brocacef.nl)

3Industry Role

Within the Netherlands' pharmaceutical supply chain, Brocacef Nl:eu HUB functions as a primary wholesaler and distributor. The company imports finished pharmaceutical formulations from international suppliers, including India, and supplies these products to various healthcare providers. This role is crucial in ensuring the availability of a wide range of pharmaceutical products to meet the diverse needs of the Dutch healthcare system. Additionally, Brocacef's operations encompass the management of its own pharmacy chain, BENU, serving the consumer market and further solidifying its position in the pharmaceutical sector. (brocacef.nl)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Brocacef Nl:eu HUB

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Brocacef Nl:eu HUB's sourcing strategy exhibits a high degree of concentration, with a total import value from India amounting to $1.7 million USD across 65 shipments. The primary supplier is INTAS Pharmaceuticals Limited, accounting for 100% of these imports. This single-source dependency may pose risks related to supply chain disruptions, such as production delays or geopolitical issues affecting trade routes. However, the consistent volume of shipments suggests a stable and well-established relationship between Brocacef and INTAS Pharmaceuticals, potentially mitigating some of these risks. The portfolio concentration, with the top five products comprising 100% of the imports, indicates a focused product strategy, which could be advantageous in terms of inventory management and supplier negotiations.

2Supply Chain Resilience

The resilience of Brocacef Nl:eu HUB's supply chain is closely tied to its exclusive reliance on INTAS Pharmaceuticals Limited for imports from India. The absence of backup suppliers for these products introduces vulnerability to potential supply chain disruptions. The limited diversity in imported formulations, with only two products across two therapeutic categories, further constrains flexibility in responding to market changes or supply issues. Additionally, the concentration of shipments through a single supplier and potentially limited shipping routes may expose the supply chain to risks associated with transportation disruptions or regulatory changes. Ensuring that INTAS Pharmaceuticals complies with international quality standards and maintains robust manufacturing practices is essential to uphold the integrity and reliability of the supply chain.

Importing Pharmaceuticals into Netherlands — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Netherlands

1Regulatory Authority & Framework

In the Netherlands, the regulatory authority overseeing pharmaceutical imports is the Dutch Medicines Evaluation Board (CBG-MEB), operating under the Ministry of Health, Welfare, and Sport (VWS). The primary legislation governing pharmaceutical imports is the Medicines Act (Geneesmiddelenwet), which aligns with European Union directives to ensure the safety, efficacy, and quality of medicinal products. The marketing authorization pathway for Indian generics involves obtaining a marketing authorization from the CBG-MEB, demonstrating compliance with EU standards. This process includes the submission of comprehensive data on the product's quality, safety, and efficacy, as well as compliance with Good Manufacturing Practice (GMP) standards. (business.gov.nl)

2Import Licensing & GMP

Importers of pharmaceutical products into the Netherlands must obtain a wholesale distribution authorization from the CBG-MEB, ensuring compliance with the European guidelines on Good Distribution Practice (GDP) of medicinal products for human use. Additionally, importers must ensure that their suppliers hold valid GMP certificates recognized by the EU, WHO, or PIC/S. These certifications confirm that the manufacturing processes meet the required quality standards. For Indian exporters, obtaining GMP certification from recognized authorities is essential to facilitate the importation of their products into the Netherlands. (business.gov.nl)

Brocacef Nl:eu HUB — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Brocacef Nl:eu HUB's product strategy focuses on importing finished pharmaceutical formulations in the therapeutic areas of diuretics and advanced oncology. The substantial import value of spironolactone, a diuretic, indicates a strong market demand for such products in the Netherlands. The inclusion of advanced oncology products suggests an alignment with the growing need for specialized cancer treatments. This strategic focus allows Brocacef to cater to critical healthcare needs, positioning itself as a key supplier in these therapeutic categories.

2Sourcing Profile

Brocacef Nl:eu HUB's sourcing strategy is centered on importing generic pharmaceutical formulations from India, particularly in the diuretics and advanced oncology categories. The exclusive reliance on INTAS Pharmaceuticals Limited for these imports indicates a focused approach to procurement. This strategy may be driven by considerations such as cost-effectiveness, product quality, and supplier reliability. For Indian exporters, understanding Brocacef's sourcing preferences and aligning with their quality standards and regulatory requirements is crucial to establish a successful partnership.

3Market Positioning

Seller's Guide — How to Become a Supplier to Brocacef Nl:eu HUB

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Brocacef Nl:eu HUB, especially if they can offer products that complement the existing portfolio or provide competitive advantages in terms of pricing, quality, or innovation. Identifying gaps in Brocacef's current sourcing, such as unmet therapeutic needs or emerging market trends, can present avenues for new suppliers to enter the market. Establishing a diversified supplier base can enhance Brocacef's supply chain resilience and responsiveness to market demands.

2Requirements & Qualifications

Indian exporters aiming to supply Brocacef Nl:eu HUB and the broader Netherlands market must ensure that their products meet the regulatory requirements set by the Dutch Medicines Evaluation Board (CBG-MEB). This includes obtaining marketing authorization, adhering to Good Manufacturing Practice (GMP) standards recognized by the EU, WHO, or PIC/S, and ensuring compliance with labeling

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Brocacef Nl:eu HUB

What products does Brocacef Nl:eu HUB import from India?

Brocacef Nl:eu HUB imports 2 pharmaceutical products across 2 categories. Top imports: Spironolactone ($1.6M), Topotecan ($70.0K).

Who supplies pharmaceuticals to Brocacef Nl:eu HUB from India?

Brocacef Nl:eu HUB sources from 1 verified Indian suppliers. The primary supplier is Intas Pharmaceuticals Limited (100.0% of imports, $5.5M).

What is Brocacef Nl:eu HUB's total pharmaceutical import value?

Brocacef Nl:eu HUB's total pharmaceutical import value from India is $1.7M, based on 65 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Brocacef Nl:eu HUB focus on?

Brocacef Nl:eu HUB imports across 2 categories. The largest: Diuretics (95.9%), Advanced Oncology (4.1%).

Get Full Brocacef Nl:eu HUB Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.